625114-66-1

Basic information

• Product Name: Carbamic acid, (5-methylpyrazinyl)-, phenyl ester
• CAS NO: 625114-66-1
• Molecular Formula: C12H11N3O2
• Molecular Weight: 229.238
• Mol File: 625114-66-1.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: Carbamic acid, (5-methylpyrazinyl)-, phenyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, (5-methylpyrazinyl)-, phenyl ester(625114-66-1)
• EPA Substance Registry System: Carbamic acid, (5-methylpyrazinyl)-, phenyl ester(625114-66-1)

Safety Data

• Hazardous Substances Data: 625114-66-1(Hazardous Substances Data)

Upstream product

• 457098-83-8 5-methyl-pyrazine-2-carbonyl azide 
• 100-51-6 benzyl alcohol 
• 5521-58-4 5-methylpyrazin-2-amine 
• 1885-14-9 phenyl chloroformate 
• 19994-56-0 2-Amino-3-cyano-5-methylpyrazine 1-oxide 

Downstream Products

• 911223-07-9 (R)-3-{4-chloro-2-[3-(5-methyl-pyrazin-2-yl)-ureido]-phenoxymethyl}-morpholine-4-carboxylic acid tert-butyl ester 
• 1020316-34-0 N-(5-methyl-pyrazin-2-yl)-4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzylidene)piperidine-1-carboxamide 
• 5521-58-4 5-methylpyrazin-2-amine 
• 631863-36-0 1-[5-chloro-2-(3-dimethylamino-propoxy)-phenyl]-3-(5-methyl-pyrazin-2-yl)-urea 

Relevant articles and documents

4- [3- (ARYLOXY) BENZYLIDENE] -3-METHYL PIPERIDINE ARYL CARBOXAMIDE COMPOUNDS USEFUL AS FAAH INHIBITORS

The present invention relates to compounds of Formula (I), wherein Ar is optionally substituted phenyl or heteroaryl and X, Y and Z are independently N or CH; or a pharmaceutically acceptable salt thereof; processes for the preparation of the compounds; intermediates used in the preparation of the compounds; compositions containing the compounds; and uses of the compounds in treating diseases or conditions associated with fatty acid amide hydrolase (FAAH) activity.

BIARYL ETHER UREA COMPOUNDS

The present invention relates to compounds of Formula (I) or a pharmaceutically acceptable salt thereof; processes for the preparation of the compounds; intermediates used in the preparation of the compounds; compositions containing the compounds; and uses of the compounds in treating diseases or conditions associated with fatty acid amide hydrolase (FAAH) activity

HETEROARYL UREA DERIVATIVES USEFUL FOR INHIBITING CHKl

Substituted urea compounds useful in the treatment of diseases and conditions related to DNA damage or lesions in DNA replication are disclosed. Methods of making the compounds, and their use as therapeutic agents, for example, in treating cancer and other diseases characterized by defects in DNA replication, chromosome segregation, or cell division, also are disclosed.